Literature DB >> 3719439

The anaesthetic management of the malignant hyperthermia susceptible parturient.

M J Douglas, G H McMorland.   

Abstract

An overall management plan for malignant hyperthermia susceptible (MHS) parturients is presented based on the experience of managing 14 of these patients. A summary of the pertinent features of their deliveries and care plus a case report of one of these parturients is described. Discussion centres around the problems of diagnosis of malignant hyperthermia susceptibility in pregnancy, the differential diagnosis and management of fever and tachycardia in a MHS parturient during labour and the use of dantrolene prophylaxis. Management of the MHS parturient in labour includes temperature and heart-rate monitoring, provision for cooling, and ready availability of a vapour-free anaesthetic machine. A large-bore intravenous infusion for hydration and for potential therapy of a MH crisis is essential. Epidural analgesia, using 2-chloroprocaine, is recommended. Emergency and elective Caesarean section anaesthesia are discussed. The importance of being prepared for a potential crisis is stressed with particular emphasis on early diagnosis by monitoring of temperature at two sites, of heart rate and rhythm with a continuous ECG and of end-tidal carbon dioxide, should a general anaesthetic be required. Recommendations are made for appropriate anaesthetic agents for both regional and general anaesthesia. Treatment of a MH crisis is outlined, with emphasis on availability of appropriate resuscitative drugs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3719439     DOI: 10.1007/bf03010752

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  19 in total

1.  Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia.

Authors:  F R Ellis; I M Clarke; M Modgill; S Currie; D G Harriman
Journal:  Br Med J       Date:  1975-08-30

2.  Hyperpyrexia during pregnancy.

Authors:  S Crawford
Journal:  Lancet       Date:  1972-06-03       Impact factor: 79.321

3.  Obstetric anesthesia for a patient with malignant hyperthermia susceptibility.

Authors:  R K Wadhwa
Journal:  Anesthesiology       Date:  1977-01       Impact factor: 7.892

4.  Unexplained hyperpyrexia during labour.

Authors:  J M Gibbs
Journal:  Anaesth Intensive Care       Date:  1984-11       Impact factor: 1.669

5.  Management of a malignant hyperthermia susceptible patient in labor with 2-chloroprocaine epidural anesthesia.

Authors:  S N Khalil; J P Williams; D L Bourke
Journal:  Anesth Analg       Date:  1983-01       Impact factor: 5.108

6.  Malignant hyperthermia in pregnancy.

Authors:  J P Cupryn; A Kennedy; R J Byrick
Journal:  Am J Obstet Gynecol       Date:  1984-10-01       Impact factor: 8.661

7.  Malignant hyperthermia.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1985-11

8.  Creatine phosphokinase (CPK) levels in pregnancy: a case report and a discussion of the value of CPK levels in the prediction of possible malignant hyperpyrexia.

Authors:  D M Isherwood; J Ridley; J Wilson
Journal:  Br J Obstet Gynaecol       Date:  1975-04

9.  Severe muscular rigidity at birth: malignant hyperthermia syndrome?

Authors:  K Sewall; R M Flowerdew; P Bromberger
Journal:  Can Anaesth Soc J       Date:  1980-05

10.  Increased carbon dioxide production in two patients with malignant hyperpyrexia and its control by dantolene.

Authors:  F Liebenschütz; C Mai; V W Pickerodt
Journal:  Br J Anaesth       Date:  1979-09       Impact factor: 9.166

View more
  3 in total

Review 1.  Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum.

Authors:  P J O'Brien
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

2.  Anaesthetic management of the malignant hyperthermia susceptible parturient.

Authors:  E Ranklev; R Fletcher
Journal:  Can J Anaesth       Date:  1987-01       Impact factor: 5.063

3.  Anaesthesia for caesarean delivery of a malignant hyperthermia susceptible parturient.

Authors:  S J Lucy
Journal:  Can J Anaesth       Date:  1994-12       Impact factor: 5.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.